EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets
Erythropoietin-producing hepatocellular carcinoma receptors (EPHs) represent the largest family of receptor tyrosine kinases (RTKs). EPH interaction with ephrins, their membrane-bound ligands, holds a pivotal role in embryonic development, while, though less active, it is also implicated in various...
Main Authors: | Ioanna E. Stergiou, Stavros P. Papadakos, Anna Karyda, Ourania E. Tsitsilonis, Meletios-Athanasios Dimopoulos, Stamatios Theocharis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/15/3963 |
Similar Items
-
The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies
by: Elena Chatzikalil, et al.
Published: (2024-03-01) -
The EPH/Ephrin System in Colorectal Cancer
by: Stavros P. Papadakos, et al.
Published: (2022-03-01) -
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
by: Stavros P. Papadakos, et al.
Published: (2023-06-01) -
EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy
by: Iason Psilopatis, et al.
Published: (2022-12-01) -
May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
by: Iason Psilopatis, et al.
Published: (2022-12-01)